MedTrace Logo

Feasibility of a New Pediatric Arm Rehabilitation Robot ChARMin

NCT02443857 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2026-05-07

No results posted yet for this study

Summary

The purpose of this study is to investigate the applicability and feasibility of the newly developed robot platform for upper extremity therapy ("ChARMin") in children undergoing neurorehabilitation.

Conditions

  • Nervous System Diseases

Interventions

DEVICE

ChARMin

The aim is to investigate the applicability (technical aspects, patient-related aspects, operability/handling of the robot, the different control modes of the device, safety and the software interface) of ChARMin.

DEVICE

ChARMin

The aim is to determine whether differences between game scores, kinematic and kinetic metrics provided by ChARMin, additionally applied physiological measures and adverse events differ when participants train with the free non-supported mode, the assist-as-needed mode and the fully guided mode.

DEVICE

ChARMin

The aim is to determine the psychometric properties (validity, reliability and responsiveness) of the assessments integrated in ChARMin.

DEVICE

ChARMin

The aim is to describe the application of the system in 30 participants and evaluate the concomitant changes in upper extremity motor function (open labelled interventional study without control group).

DEVICE

ChARMin

The aim is to perform specific motor learning studies in 120 patients investigating whether children with neurological diagnoses can improve arm and hand task performance during repetitive training with ChARMin, are able to retain improved levels of task performance and how task performance is influenced by other interventions.

DEVICE

ChARMin

The aim is to perform an ecological study monitoring safety, functional progress and (changes in) the application of ChARMin in 120 participants following an in- or out-patient program (comparable to subproject ChARMin-4).

Sponsors & Collaborators

  • Huub van Hedel

    lead OTHER

Principal Investigators

  • Hubertus JA van Hedel, PhD · Rehabilitation Center for Children and Adolescents of the University Children's Hospital Zurich

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-01
Primary Completion
2024-06-06
Completion
2025-05-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02443857 on ClinicalTrials.gov